Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | THRA | P10827 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.33 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17358260 | 0.93 | PTPN1 (0.43) | TSHRHPGDABCB1PTPN1GPR84 | |
| SCHEMBL17358269 | 0.88 | FFAR4 (0.40) | TSHRGPR84FFAR1FFAR4 | |
| SCHEMBL17358262 | 0.87 | PTPN1 (0.47) | TSHRHPGDABCB1PTPN1GPR84 | |
| SCHEMBL14256441 | 0.86 | FFAR4 (0.48) | TSHRPTPN1GPR84FFAR1FFAR4 | |
| SCHEMBL19862648 | 0.86 | PTPN1 (0.38) | TSHRHPGDABCB1PTPN1FFAR1 | |
| SCHEMBL17358270 | 0.86 | FFAR4 (0.48) | TSHRPTPN1GPR84FFAR1FFAR4 | |
| SCHEMBL20143064 | 0.85 | PTPN1 (0.37) | TSHRHPGDABCB1PTPN1GPR84 | |
| SCHEMBL13968351 | 0.84 | PPARG (0.40) | TSHRABCB1PTPN1 | |
| SCHEMBL28391986 | 0.81 | TSHR (0.43) | TSHRHPGDABCB1GPR84FFAR1 | |
| SCHEMBL28195499 | 0.81 | TSHR (0.43) | TSHRHPGDABCB1GPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9834626-B2 | Plant oil-based materials | NDSU RESEARCH FOUNDATION (US) | 2017-12-05 | — | — | US | disclosed |
| US-9834626-B2 | Plant oil-based materials | NDSU RESEARCH FOUNDATION (US) | 2017-12-05 | — | — | US | disclosed |
| US-20150368378-A1 | PLANT OIL-BASED MATERIALS | NDSU RESEARCH FOUNDATION (US) | 2015-12-24 | — | — | US | disclosed |
| US-20150368378-A1 | PLANT OIL-BASED MATERIALS | NDSU RESEARCH FOUNDATION (US) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368378-A1 | PLANT OIL-BASED MATERIALS | FASN, LIPC, PNLIP | TSHR 2917/4885HPGD 1274/4885ABCB1 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.